Free prostate specific antigen

An isoform of PSA the percentage of which is lower in patients with prostate cancer than in those with benign prostatic hypertrophy.

In patients with clinically localized prostate cancer the free/total PSA ratio does not predict for the final pathological tumor stage or grade and adds nothing to the PSA and Gleason score.

Leave a Reply

Your email address will not be published. Required fields are marked *